Skip to main content
Log in

Clostridium difficile-associated disease in children with solid tumors

  • Short Communication
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Goals of work

The goal of this study was to describe the incidence of Clostridium difficile-associated disease (CDAD) in children with solid tumours.

Patients and methods

After documentation of a case of C. difficile-associated pseudomembranous colitis in a patient with neuroblastoma, the presence of C. difficile toxins A and B was prospectively tested in all children undergoing antineoplastic chemotherapy for solid tumours or lymphomas at the “G. Gaslini” Children Hospital in Genoa who presented abdominal pain.

Main results

From January 2005 to December 2006, nine (6%) out of 141 patients treated for solid tumours had C. difficile toxin A detected in their stools in the presence of abdominal symptoms including vomit, abdominal pain and diarrhoea. The majority of patients had a normal neutrophil count at onset of gastrointestinal disease No patient developed pseudomembranous colitis, and none died. All patients received antibiotics and/or antineoplastic drugs previously associated with CDAD.

Conclusions

CDAD may be a complication of children with solid tumours. Since this disease may be life threatening and cause epidemic clusters, this possibility must be kept in mind for the differential diagnosis of abdominal diseases in children with cancer, especially in absence of neutropenia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Anand A, Glatt AE (1993) Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis 17:109–113

    PubMed  CAS  Google Scholar 

  2. Anonimous (1994) Clostridium difficile. In: Philpott-Howard J, Casewell M (eds) Hospital infection control. Policies & practical procedures. Saunders, London, pp 62–64

    Google Scholar 

  3. Bilgrami S, Feingold JM, Dorsky D, Edwards RL, Bona RD, Khan AM et al (1999) Incidence and outcome of Clostridium difficile infection following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 23:1039–1042 doi:10.1038/sj.bmt.1701773

    Article  PubMed  CAS  Google Scholar 

  4. Brito GA, Sullivan GW, Ciesla WP Jr, Carper HT, Mandell GL, Guerrant RL (2002) Clostridium difficile toxin A alters in vitro-adherent neutrophil morphology and function. J Infect Dis 185:1297–1306 doi:10.1086/340236

    Article  PubMed  CAS  Google Scholar 

  5. Collignon A, Chaumard C, Vallet-Collomb I, Delepine N (1988) Clostridium difficile in children and adolescents undergoing anticancer and antimicrobial chemotherapy. The possibility of nosocomial acquisition. Pathol Biol (Paris) 36:754–758

    CAS  Google Scholar 

  6. Correa AG (2004) Clostridial Intoxication and infection. In: Feigin RD, Cherry JD, Demmler GJ, Kaplan SL (eds) Textbook of pediatric infectious diseases. Saunders, Philadelphia, pp 1751–1758

    Google Scholar 

  7. Cudmore MA, Silva J Jr, Fekety R, Liepman MK, Kim KH (1982) Clostridium difficile colitis associated with cancer chemotherapy. Arch Intern Med 142:333–335 doi:10.1001/archinte.142.2.333

    Article  PubMed  CAS  Google Scholar 

  8. Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ (2007) Clostridium difficile–associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 45:1543–1549 doi:10.1086/523582

    Article  PubMed  Google Scholar 

  9. Kelly CP, Pothoulakis C, LaMont JT (1994) Clostridium difficile colitis. N Engl J Med 330:257–262 doi:10.1056/NEJM199401273300406

    Article  PubMed  CAS  Google Scholar 

  10. Laret V, Sion C, Bataille C, Hustinx R, Reginster M (2006) Clinical case of the month: clostridium difficile colitis. Rev Med Liege 61:750–752

    PubMed  CAS  Google Scholar 

  11. Miller SD, Koornhof HJ (1984) Clostridium difficile colitis associated with the use of antineoplastic agents. Eur J Clin Microbiol 3:10–13 doi:10.1007/BF02032807

    Article  PubMed  CAS  Google Scholar 

  12. Missaghi B, Valenti AJ, Owens RCJ (2008) Clostridium difficile Infection: A Critical Overview. Curr Infect Dis Rep 10:165–173 doi:10.1007/s11908-008-0028-5

    Article  PubMed  Google Scholar 

  13. Morris AM, Jobe BA, Stoney M, Sheppard BC, Deveney CW, Deveney KE (2002) Clostridium difficile colitis: an increasingly aggressive iatrogenic disease? Arch Surg 137:1096–1100 doi:10.1001/archsurg.137.10.1096

    Article  PubMed  Google Scholar 

  14. Pothoulakis C, Sullivan R, Melnick DA, Triadafilopoulos G, Gadenne AS, Meshulam T et al (1988) Clostridium difficile toxin A stimulates intracellular calcium release and chemotactic response in human granulocytes. J Clin Invest 81:1741–1745 doi:10.1172/JCI113514

    Article  PubMed  CAS  Google Scholar 

  15. Schuller I, Saha V, Lin L, Kingston J, Eden T, Tabaqchali S (1995) Investigation and management of Clostridium difficile colonisation in a paediatric oncology unit. Arch Dis Child 72:219–222

    Article  PubMed  CAS  Google Scholar 

  16. Simon A, Ammann RA, Bode U, Fleischhack G, Wenchel HM, Schwamborn D et al (2008) Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland. BMC Infect Dis 8:70 doi:10.1186/1471-2334-8-70

    Article  PubMed  Google Scholar 

  17. Thielman NM, Wilson KH (2005) Antibiotic-associated colitis. In: Mandell GL, Bennett JE, Doolin R (eds) Principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, pp 1249–1263

    Google Scholar 

  18. Viscoli C, Castagnola E (2005) Prophylaxis and empirical therapy for infection in cancer patients. In: Mandell GL, Bennett JE, Doolin R (eds) Principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, pp 3442–3462

    Google Scholar 

  19. Wehl G, Allerberger F, Heitger A, Meister B, Maurer K, Fink FM (1999) Trends in infection morbidity in a pediatric oncology ward, 1986–1995. Med Pediatr Oncol 32:336–343 doi:10.1002/(SICI)1096-911X(199905)32:5<336::AID-MPO5>3.0.CO;2-4

    Article  PubMed  CAS  Google Scholar 

  20. Wilcox MH, Fawley WN, Wigglesworth N, Parnell P, Verity P, Freeman J (2003) Comparison of the effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. J Hosp Infect 54:109–114 doi:10.1016/S0195-6701(02)00400-0

    Article  PubMed  CAS  Google Scholar 

  21. Wilcox MH, Fawley WN, Wigglesworth N, Parnell P, Verity P, Freeman J (2004) Detergent versus hypochlorite cleaning and Clostridium difficile infection. J Hosp Infect 56:331 doi:10.1016/j.jhin.2004.01.027

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Elio Castagnola.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Castagnola, E., Battaglia, T., Bandettini, R. et al. Clostridium difficile-associated disease in children with solid tumors. Support Care Cancer 17, 321–324 (2009). https://doi.org/10.1007/s00520-008-0507-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-008-0507-0

Keywords

Navigation